abstract |
The present application describes a MIP-1 modulator having formula (I), or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein m, Q, T, W, Z, R 1 , R 3 , R 4 , R 5 , R 5a and R 5b are as described in the specification. In addition, the present application discloses methods of using the modulators to treat and prevent inflammatory diseases such as asthma and allergic diseases, and autoimmune pathologies such as rheumatoid arthritis and transplant rejection. |